Drugs / Polygam® S/D
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 1/2 | NCT00068055 Comparator | Sep 2003 → Dec 2006 | Flaviviridae infectious disease | National Institute of Allergy and Infectious Diseases (NIAID) | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Polygam S/D | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00068055 ↗ |
| Modality | Protein / enzyme biologic | “Polygam® S/D is a solvent/detergent treated, sterile, freeze-dried preparation of highly purified immunoglobulin G (IgG) derived from large pools of human plasma.” NCT00068055 ↗ |
| Route | Intravenous | “Patients will receive a single intravenous dose of study medication or one of two placebos.” NCT00068055 ↗ |